Obsidian Therapeutics Inc. (OBX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$1.04B

MomentumView details →

1D Return

−1.58%

YTD Return

—

RSI (14)

48.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$1.04B

RSI (14)

48.5

MomentumView details →

1D Return

−1.58%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$2.05

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

0.00%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsNov 17, 2026 →

Latest newsMore news →

No recent news for OBX.

Similar companies

Cloudbreak Pharma Inc.02592.HK Faeth Therapeutics, Inc.FTH Avalo Therapeutics, Inc.AVTX Arbutus Biopharma CorporationABUS Geron CorporationGERN Ventyx Biosciences, Inc.VTYX Find similar companies →

Latest newsMore news →

No recent news for OBX.